Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

NCT01547728 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped Too many barriers to enroll participants.

Conditions

Thrombophilia Due to Acquired Antithrombin III Deficiency

Interventions

DRUG: Recombinant antithrombin (rhAT)

Sponsor

Mayo Clinic

Collaborators

[object Object]